The AI market in pharmaceuticals is projected to reach $16.49 billion by 2034, while AI-driven medical devices are expected to grow to $97.07 billion by 2028. Despite the increasing adoption of AI, widespread implementation remains a challenge for many organizations. Read more: https://pharma.economictimes.indiatimes.com/news/pharmatech/ey-parthenon-microsoft-report-charts-key-drivers-for-successful-ai-implementation-at-bioasia-2025/118556595